Mesalazine-induced neutropenia: a rare idiosyncratic reaction
Year: 2025
Type: article
Study design: Case Report
Abstract: Mesalazine is a 5-aminosalicylate commonly used in the treatment of ulcerative colitis. It has been very rarely associated with neutropenia. We report a woman in her 30s who developed neutropenia 2 years after starting mesalazine. She had not been started on any other medications and extensive investigation for alternative causes of neutropenia were unremarkable. Mesalazine was discontinued and her neutrophil count normalised within 2 weeks.
Source: BMJ Case Reports
Authors: Deloshaan Subhaharan, Waled Mohsen
Institutions: Bond University, Gold Coast Hospital
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4414189594